Literature DB >> 3940999

Modulation of bone metabolism by two chemically distinct lipopolysaccharide fractions from Bacteroides gingivalis.

S J Millar, E G Goldstein, M J Levine, E Hausmann.   

Abstract

Two separate species of lipopolysaccharide (LPS) from Bacteroides gingivalis 381 have been isolated. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis demonstrated not only the heterogeneity of each species, but also that they represented high- and low-molecular-weight LPS entities. Although both contained the same carbohydrate and fatty acid components, the proportions of these differed between the LPS species. The direct effects of these two species in modulation of bone resorption and bone collagen and noncollagen protein synthesis have been examined. In a bone resorption assay, these two species stimulated 45Ca release from prelabeled fetal rat bones in a concentration range of 0.5 to 3.0 micrograms/ml. The two LPS species also elicited a 30 to 40% reduction in collagen protein formation at 10 micrograms/ml. Responses of the same order of magnitude were observed with LPS from Salmonella minnesota at 10 micrograms/ml. The higher-molecular-weight LPS species also significantly inhibited noncollagen protein formation. This is the first report that LPS from B. gingivalis 381, a suspected periodontal pathogen, inhibits bone collagen formation and, in conjunction with the bone resorption potency, further implicates LPS in alveolar bone loss associated with periodontal disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3940999      PMCID: PMC261102          DOI: 10.1128/iai.51.1.302-306.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Immunochemical and biologic studies of the lipopolysaccharide of Bacteroides melaninogenicus subspecies asaccharolyticus.

Authors:  B J Mansheim; A B Onderdonk; D L Kasper
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

2.  The predominant cultivable microflora of advanced periodontitis.

Authors:  J Slots
Journal:  Scand J Dent Res       Date:  1977 Jan-Feb

Review 3.  The biosynthesis of collagen. 1.

Authors:  M E Grant; D J Prockop
Journal:  N Engl J Med       Date:  1972-01-27       Impact factor: 91.245

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Effect of phosphate, calcium and magnesium on bone resorption and hormonal responses in tissue culture.

Authors:  L G Raisz; I Niemann
Journal:  Endocrinology       Date:  1969-09       Impact factor: 4.736

6.  Electrodialysis of lipopolysaccharides and their conversion to uniform salt forms.

Authors:  C Galanos; O Lüderitz
Journal:  Eur J Biochem       Date:  1975-06

7.  Lipopolysaccharide-induced bone resorption is mediated by prostaglandins.

Authors:  S D Meryon; A D Perris
Journal:  Life Sci       Date:  1981-03-02       Impact factor: 5.037

8.  Lipopolysaccharide heterogeneity in Salmonella typhimurium analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis.

Authors:  E T Palva; P H Mäkelä
Journal:  Eur J Biochem       Date:  1980

9.  Longitudinal study of experimentally induced periodontal disease in Macaca arctoides: relationship between microflora and alveolar bone loss.

Authors:  J Slots; E Hausmann
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

10.  A study of the bacteria associated with advancing periodontitis in man.

Authors:  A C Tanner; C Haffer; G T Bratthall; R A Visconti; S S Socransky
Journal:  J Clin Periodontol       Date:  1979-10       Impact factor: 8.728

View more
  22 in total

Review 1.  Bacterially induced bone destruction: mechanisms and misconceptions.

Authors:  S P Nair; S Meghji; M Wilson; K Reddi; P White; B Henderson
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Strain-dependent activation of monocytes and inflammatory macrophages by lipopolysaccharide of Porphyromonas gingivalis.

Authors:  L Shapira; C Champagne; T E Van Dyke; S Amar
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

3.  Effect of anaerobiosis on the surface ultrastructure and surface proteins of Actinobacillus actinomycetemcomitans (Haemophilus actinomycetemcomitans).

Authors:  F A Scannapieco; S J Millar; H S Reynolds; J J Zambon; M J Levine
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

Review 4.  Biology of asaccharolytic black-pigmented Bacteroides species.

Authors:  D Mayrand; S C Holt
Journal:  Microbiol Rev       Date:  1988-03

5.  Protective immunization against experimental Bacteroides (Porphyromonas) gingivalis infection.

Authors:  P B Chen; L B Davern; R Schifferle; J J Zambon
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

6.  Role of Porphyromonas gingivalis-derived fibroblast-activating factor in bone resorption.

Authors:  J Mihara; T Yoneda; S C Holt
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

7.  Effects of Porphyromonas gingivalis and Escherichia coli lipopolysaccharides on mononuclear phagocytes.

Authors:  F A Roberts; G J Richardson; S M Michalek
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

8.  Characterization of inhibitory effects of suspected periodontopathogens on osteogenesis in vitro.

Authors:  P M Loomer; R P Ellen; H C Tenenbaum
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

9.  Porphyromonas gingivalis induces receptor activator of NF-kappaB ligand expression in osteoblasts through the activator protein 1 pathway.

Authors:  Nobuo Okahashi; Hiroaki Inaba; Ichiro Nakagawa; Taihei Yamamura; Masae Kuboniwa; Koji Nakayama; Shigeyuki Hamada; Atsuo Amano
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

10.  Effect of lipopolysaccharide on proteoglycan synthesis by adult human gingival fibroblasts in vitro.

Authors:  P M Bartold; S J Millar
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.